Finance

Beta
Lists
DAP:ETR
Danaher Corp
157,35 €
+2,57%
(+3,95) 1D
29 մյս, 17:35:42 GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for DAP...
Open
154,40 €
High
157,35 €
Low
154,35 €
Mkt. cap
129,29 մլրդ
Avg. vol.
868,00
Volume
526,00
52-wk high
208,30 €
52-wk low
138,20 €
No. of employees
59 հզր
Open
154,40 €
High
157,35 €
Low
154,35 €
Mkt. cap
129,29 մլրդ
Avg. vol.
868,00
Volume
526,00
52-wk high
208,30 €
52-wk low
138,20 €
No. of employees
59 հզր
News stories
From sources across the web
Profile
Danaher Corporation is an American healthcare company headquartered in Washington, D.C.. It develops products used for advances in biotechnology, life sciences, and diagnostics. The company operates three divisions: biotechnology, which develops products for the development of therapeutics; life sciences, which develops products to identify causes of disease, new therapies, and to test and manufacture new drugs, vaccines and gene editing technologies; and diagnostics, which develops instruments, consumables, and software and services to diagnose diseases. Danaher was founded in 1984 by brothers Steven Rales and Mitchell Rales; it was named after Danaher Creek in Western Montana, where the brothers came up with the idea for the company while fishing. The company is ranked 180th on the Fortune 500 and 241st on the Forbes Global 2000. Wikipedia
About Danaher Corp
CEORainer M. Blair
Employees59 հզր
Founded1969
Headquarters-
Sector-
Websitedanaher.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
2025 թ. հնս
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
Revenue
5,94 մլրդ
6,05 մլրդ
6,84 մլրդ
5,95 մլրդ
Cost of goods sold
2,41 մլրդ
2,53 մլրդ
2,86 մլրդ
2,36 մլրդ
Cost of revenue
2,41 մլրդ
2,53 մլրդ
2,86 մլրդ
2,36 մլրդ
Research and development expenses
403,00 մլն
378,00 մլն
438,00 մլն
387,00 մլն
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,93 մլրդ
1,89 մլրդ
2,03 մլրդ
1,84 մլրդ
Operating expense
2,33 մլրդ
2,27 մլրդ
2,46 մլրդ
2,23 մլրդ
Total operating expenses
4,74 մլրդ
4,80 մլրդ
5,32 մլրդ
4,59 մլրդ
Operating income
1,19 մլրդ
1,26 մլրդ
1,52 մլրդ
1,36 մլրդ
Other non operating income
-
-
-87,00 մլն
-
EBT including unusual items
655,00 մլն
1,08 մլրդ
1,37 մլրդ
1,24 մլրդ
EBT excluding unusual items
1,13 մլրդ
1,19 մլրդ
1,39 մլրդ
1,33 մլրդ
Income tax expense
100,00 մլն
168,00 մլն
190,00 մլն
206,00 մլն
Effective tax rate
15,27%
15,61%
13,84%
16,68%
Other operating expenses
-
-
-
-
Net income
555,00 մլն
908,00 մլն
1,20 մլրդ
1,03 մլրդ
Net profit margin
9,35%
15,00%
17,51%
17,29%
Earnings per share
1,80
1,89
2,23
2,06
Interest and investment income
8,00 մլն
3,00 մլն
13,00 մլն
27,00 մլն
Interest expense
-71,00 մլն
-67,00 մլն
-55,00 մլն
-63,00 մլն
Net interest expenses
-63,00 մլն
-64,00 մլն
-42,00 մլն
-36,00 մլն
Depreciation and amortization charges
-
-
-
-
EBITDA
1,80 մլրդ
1,88 մլրդ
2,14 մլրդ
1,99 մլրդ
Gain or loss from assets sale
-81,00 մլն
-9,00 մլն
9,00 մլն
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer